Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Allergy and Clinical Immunology |
Vol/bind | 142 |
Udgave nummer | 6 |
Sider (fra-til) | 1983-1987 |
ISSN | 0091-6749 |
DOI | |
Status | Udgivet - 2018 |
ID: 203666327